World Antiviral Congress 2020

THURSDAY 12 NOVEMBER 2020

VIRTUAL LIVE EVENT

BriNging translational antiviral drug discovery and development to the market

THE NEED FOR THE NEW ANTIVIRAL AGENT

Evident with every viral pandemic including COVID-19, rapid deployment of compatible antiviral therapies is of paramount importance, particularly before a long-term strategy of a vaccine is possible.

Antivirals can prevent or control viral diseases from emerging diseases, respiratory infections, chronic diseases to virus-associated tumours.

Join us on this virtual congress to get up to speed and help accelerate your antiviral research from bench to patient.

Brought to you by the World Vaccines Congress Series team

EVENT UPDATES

For event updates, discounts and latest news sign up now.

Sign Up for Event Updates

TOP SPEAKERS FROM OUR VACCINE SERIES

Some of the most exciting industry speakers participate in the series including:

Dr Tedros Adhanom Ghebreyesus
Director General
WHO

Dr Anthony S. Fauci, M.D.
NIAID Director
NIH

Dr Marco Cavaleri;
Head of Office, Anti-infective and Vaccines in the Human, Medicines Evaluation Division
EMA

Dr Kate O’Brien;
Director, Department of Immunization, Vaccines and Biologicals;
WHO

Dr Sarah Gilbert
Prof of Vaccinology
Jenner Institute, University of Oxford

Dr Mariola Fotin-Mleczek
CSO
Curevac

Prof. Jean-Jacques Muyembe-Tamfum
Director-General, National Institute for Biomedical Research, Democratic Republic of the Congo (DRC) & Professor of Microbiology
Kinshasa University Medical School

Dr Richard Hatchett
CEO
CEPI

Dr Klaus Cichutek
Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Germany & Professor of Biochemistry
Goethe University Frankfurt/Main

Marion Gruber
Director, OVRR, CBER
FDA

Dr Paul Stoffels
Vice Chairman of the Executive Committee and Chief Scientific Officer
Janssen

Dr John Markels
President
Merck Vacines

APPLY TO SPEAK

ANTIVIRAL CONGRESS FEATURES:

World Antiviral Congress

Exclusive
Interviews

World Antiviral Congress

World Leading
Presentations

World Antiviral Congress

Interactive
Roundtables

World Antiviral Congress

Live Panel
Debates

World Antiviral Congress

Virtual Face-to-Face Meetings

World Antiviral Congress

Webinars
All Year Round

ENQURE TO SPEAK

"The third breakthrough will be in antiviral drugs. These have been an underinvested branch of science. We haven’t been as effective at developing drugs to fight viruses as we have those to fight bacteria. But that will change. Researchers will develop large, diverse libraries of antivirals, which they’ll be able to scan through and quickly find effective treatments for novel viruses."

Bill Gates, writing in The Economist, April 23 2020